{
    "study_accession": "SDY8",
    "actual_completion_date": "2008-09-23",
    "actual_enrollment": 67,
    "actual_start_date": "2007-08-21",
    "age_unit": "Years",
    "brief_description": "To evaluate AD subjects cell mediated immunity CMI responses to Herpes simplex virus.",
    "brief_title": "ADVN Biomarker Registry Study: CMI-HSV Substudy",
    "clinical_trial": "Y",
    "condition_studied": "Atopic Dermatitis               Eczema Herpeticum            ",
    "dcl_id": 2,
    "description": "To evaluate AD subjects cell mediated immunity CMI responses to Herpes simplex virus.",
    "doi": "10.21430/M3GCZX3F7X",
    "endpoints": "<ol type=1><li>A broad measure of HSV-specific CMI responses will be evaluated by measuring IFN&gamma; production observed after subjects PBMCs are stimulated with HSV using Enzyme-linked immunosorbent spot (ELISPOT) technology.</li><li>The cytotoxic T lymphyocyte (CTL) activity observed in response to HSV stimulation will be assessed by measuring expression of CD107a in both CD4 and CD8 cells. Both CD4 and CD8 may exert CTL activity against HSV.</li><li>The CD4 Th1 responses observed following HSV-stimulated CD4 cells will be assessed by intracellular flow cytometric analysis for IL2, IL-17 and IFN&gamma;.</li><li>The CD4 Th2 responses observed following HSV-stimulated CD4 cells will be assessed by intracellular flow cytometric analysis for IL10, IL-13 and IL-22.</li><li>CD8 Th1 responses observed following HSV-stimulated CD8 cells will be assessed by intracellular flow cytometric analysis for TNF&alpha; and IFN&gamma;.</li><li>CD8 Th2 responses observed following HSV-stimulated CD8 cells will be assessed by intracellular flow cytometric analysis for IL10 and IL13. </li><li>HSV-specific antigen presenting cell (APC) function will be assessed by measurement of IL10, IFN&gamma; and TNF&alpha; synthesis of HSV-stimulated CD14+ cells.</li><li>Natural Killer (NK) function in response to HSV in vitro stimulation assessed by CD107 and IFN&gamma; expression. </li><li>IL-22 synthesis observed following HSV-stimulated CD4+ cells.</li></ol>",
    "gender_included": "Female, Male",
    "hypothesis": "ADEH+ subjects have impaired HSV-specific T cell responses, which puts them at risk for the development of ADEH",
    "initial_data_release_date": "2012-11-16",
    "initial_data_release_version": "DR1",
    "intervention_agent": "NA\r",
    "latest_data_release_date": "2017-04-21",
    "latest_data_release_version": "DR21",
    "maximum_age": "  64.00",
    "minimum_age": "   1.00",
    "objectives": "To measure the T cell-mediated immune responses to HSV (ex vivo) and NK cells in ADEH+, ADEH-, and NA control subjects.",
    "official_title": "ADVN Biomarker Registry Study: CMI-HSV Substudy",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 60,
    "workspace_id": 1089,
    "research_focus": [
        "Atopy/Allergy"
    ],
    "arm": [
        {
            "arm_accession": "ARM263",
            "description": "Atopic Dermatitis subjects with previous or current eczema herpeticum.",
            "name": "AD+ EH+"
        },
        {
            "arm_accession": "ARM264",
            "description": "Atopic Dermatitis subjects without eczema herpeticum.",
            "name": "AD+ EH-"
        },
        {
            "arm_accession": "ARM265",
            "description": "Nonatopic/healthy control subjects without eczema herpeticum. ",
            "name": "Healthy controls"
        }
    ],
    "personnel": [
        {
            "first_name": "Donald",
            "last_name": "Leung",
            "organization": "National Jewish Health",
            "role_in_study": "Principal Investigator",
            "site_name": "National Jewish Health\r"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Atopic Dermatitis & Vaccinia Network (ADVN)",
            "contract_name": "Atopic Dermatitis and Vaccinia Network (ADVN) Clinical Studies Consort-26629c"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISA",
            "number_of_expsamples": 251
        },
        {
            "measurement_technique": "ELISPOT",
            "number_of_expsamples": 64
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Black or African American",
                "count": 25
            },
            {
                "race": "Other",
                "count": 1
            },
            {
                "race": "White",
                "count": 41
            }
        ],
        "gender": [
            {
                "Female": 39
            },
            {
                "Male": 28
            }
        ]
    }
}
